Martin Latterich - 17 Feb 2022 Form 4 Insider Report for Histogen Inc.

Role
SVP, Technical Operations
Signature
/s/ Susan A. Knudson as attorney-in-fact for Martin Latterich
Issuer symbol
N/A
Transactions as of
17 Feb 2022
Net transactions value
$0
Form type
4
Filing time
22 Feb 2022, 17:18:41 UTC
Previous filing
10 Nov 2021
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction HSTO Stock Option (right to buy) Award $0 +134,900 $0.000000 134,900 17 Feb 2022 Common Stock 134,900 $0.2400 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 1/4 of the shares subject to the option vest one year after the date of grant, on 2/17/2023, and the remaining 1/36 of the shares vest on a monthly basis thereafter.